10.1016/s1470-2045(14)70361-4 - Active monitoring, radical prostatect...

This document has been corrected

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial

10.1016/s1470-2045(14)70361-4

Published Online: 2014-09-?

Journal: The Lancet Oncology•Publisher: Elsevier BV

Authors: Chris Metcalfe•Daniel Dedman•David E Neal•Eleanor Walsh•Emma L Turner•Freddie C Hamdy•J Athene Lane•Jenny L Donovan•Liz Down•Malcolm D Mason•Michael Davis•Richard M Martin•Tim J Peters

This document has been corrected

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial

10.1016/s1470-2045(14)70361-4

Published Online: 2014-09-?

Journal: The Lancet Oncology

NOW

2014-10-01•Erratum

Correction to Lancet Oncol 2014; 15: 1109–18

10.1016/s1470-2045(14)70505-4

* information provided by CrossRef

2014-10-01•Erratum

10.1016/s1470-2045(14)70505-4

* information provided by CrossRef

2014-09-?•Published

2014-10-01•Erratum

Correction to Lancet Oncol 2014; 15: 1109–18

10.1016/s1470-2045(14)70505-4

* information provided by CrossRef

This document has been corrected

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial

10.1016/s1470-2045(14)70361-4

Published Online: 2014-09-?

Journal: The Lancet Oncology•Publisher: Elsevier BV